Defense Production Act: Opportunities Exist to Increase Transparency and Identify Future Actions to Mitigate Medical Supply Chain Issues, Report to Congressional Committees [open pdf - 552KB]
From the Highlights: "COVID-19 [coronavirus disease 2019] has put the U.S. health care system under severe strain, including affecting the federal government's ability to buy and maintain critical medical supplies to treat patients and protect health care workers. In March 2020 agencies began using DPA [Defense Production Act] authorities to rapidly obtain and expand domestic production of medical supplies for COVID-19. The CARES [Coronavirus Aid, Relief, and Economic Security] Act provided the Department of Defense (DOD) $1 billion for DPA purchases related to COVID-19. HHS [Department of Health and Human Services] also reported using some of the $8.4 billion it obligated to buy supplies and replenish the Strategic National Stockpile to increase domestic production of medical supplies, which GAO [Government Accountability Office] refers to as similar actions. The CARES Act includes a provision for GAO to monitor funds provided for the COVID-19 pandemic. This report examines (1) federal agencies' use of these actions to address COVID-19, and (2) the federal approach for using DPA and similar actions for medical supplies, among other issues."
Government Accountability Office: http://www.gao.gov/